Recent articles
Here's Why Axsome Therapeutics Fell as Much as 14.7% Today
An important clinical trial delivered mixed results.
Will a Strong Balance Sheet Protect Renewable Energy Group?
Selling prices for crude oil and biomass-based diesel are crashing at the worst possible time for the business.
Beyond Meat Stock Pops on Stimulus Hopes, but Is It Premature?
Investors are anticipating a massive stimulus deal -- but it's only meant to soften the economic blow, not avoid it altogether.
Lithium Demand for Electric Vehicles Could Grow 599% by 2025
The projections are likely to take a hit from the coronavirus pandemic, but the future for lithium remains strong.
Here's Why The Best Is Yet to Come for Axsome Therapeutics
There are tangible near-term risks to the business in the face of the coronavirus pandemic, but investors with a long-term mindset could find this pharma stock attractive.
Here's Why Gold and Silver Stocks Jumped Today
The market's wild ride through March continued, lifting prices of gold and silver from recent lows.
Alliance Resource Partners Stock Keeps Falling
The dividend stock is no stranger to volatility, but this time might be different.
Inovio Pharmaceuticals Continues to Sink Lower
Investors might be coming to grips with the long odds facing the company.
Genetic Testing Stocks Rise Again as Volatility Continues
Have these growth stocks bottomed out? That's probably the wrong question to ask.
Here's Why American Water Works Stock Is Tumbling Today
Investors might be worrying that the company's customer mix makes it vulnerable during the unfolding crisis. That would be a misplaced concern.
Here's Why Beyond Meat Has Tumbled to a 1-Year Low
Restaurants and food service sales channels were responsible for 51% of total revenue in 2019.
Amyris Provides Update to Investors, but Not the Numbers Needed
The business needs to provide GAAP revenue and GAAP product gross margin for its consumer brands to reassure nervous investors.
Here's Why Gold Stocks Soared Today
The combination of market volatility and a federal stimulus is aiding gold and silver stocks.
Here's Why Genetic Testing Stocks Are Down Today
Investors should prepare for the genetic testing industry to see a tangible slowdown in volumes due to the coronavirus pandemic.
Here's Why Solar Hardware Stocks Are Down
The latest economic numbers from China were worse than expected, which hints at pain to come for industries with supply chains in the country.
Amyris Is Spending Way Too Much on Manufacturing Costs
Can the industrial biotech amend its manufacturing agreement to lower expenses? Will it matter?
Invitae Stock Falls Again in Broader Market Downturn
It's been a rough few weeks for shareholders, but portfolio returns aren't measured in weeks.
Here's Why Invitae Stock Dropped Today
Growth stocks often fall the hardest during a market correction.
Here's Why Avid Bioservices Tumbled Today
The drug manufacturer encountered an operational setback, which forced it to slash revenue guidance.
Here's Why Editas Medicine Fell as Much as 11.8% Today
The gene-editing pioneer is getting caught in the broader market correction, which isn't too surprising considering the stock's big gains last week.